J. Scott Wolchko is CEO & President at FATE THERAPEUTICS INC (FATE). They have made 27 open-market trades across 1 company since 2014, most recently 2024-01-09.
CIK 0001586893
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FATE | 371,248 | $661K |
Shares reported on the most recent Form 4, priced at the 2024-01-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FATE | SELL | 2024-01-09 | 2024-01-10 | $4.37 | $126K | +7.6% | +40.1% | +50.6% |
| FATE | SELL | 2023-01-10 | 2023-01-11 | $5.24 | $481K | -5.2% | +8.6% | -1.6% |
| FATE | SELL | 2022-07-21 | 2022-07-25 | $32.74 | $2.4M | +6.1% | -0.2% | -38.4% |
| FATE | SELL | 2022-04-21 | 2022-04-25 | $34.80 | $2.6M | -21.7% | -37.1% | -11.5% |
| FATE | SELL | 2022-01-20 | 2022-01-24 | $39.33 | $2.0M | -0.7% | -16.5% | -7.0% |
| FATE | SELL | 2022-01-11 | 2022-01-13 | $48.68 | $1.4M | -5.3% | -12.2% | -6.1% |
| FATE | SELL | 2022-01-10 | 2022-01-12 | $46.86 | $3.2M | -11.0% | -15.6% | -17.5% |
| FATE | SELL | 2021-11-18 | 2021-11-22 | $54.27 | $1.1M | -8.5% | +22.2% | -36.8% |
| FATE | SELL | 2021-10-21 | 2021-10-25 | $59.77 | $5.4M | +2.3% | -6.7% | -32.2% |
| FATE | SELL | 2021-08-19 | 2021-08-20 | $88.01 | $1.8M | +11.3% | -0.7% | -18.7% |
| FATE | SELL | 2021-07-22 | 2021-07-26 | $85.77 | $7.6M | +16.8% | -10.8% | -28.9% |
| FATE | SELL | 2021-05-20 | 2021-05-24 | $77.16 | $1.5M | -1.6% | +12.9% | -2.3% |
| FATE | SELL | 2021-04-22 | 2021-04-26 | $85.39 | $5.1M | -16.3% | -16.4% | -9.3% |
| FATE | SELL | 2021-02-18 | 2021-02-19 | $102.01 | $4.1M | -17.9% | -14.7% | -28.3% |
| FATE | SELL | 2021-01-21 | 2021-01-22 | $100.69 | $11.1M | +0.5% | +3.3% | -13.8% |
| FATE | SELL | 2021-01-08 | 2021-01-12 | $116.48 | $14.9M | -15.1% | -9.5% | -33.8% |
| FATE | SELL | 2020-12-17 | 2020-12-18 | $91.81 | $3.7M | -2.5% | +22.6% | -7.8% |
| FATE | SELL | 2020-11-12 | 2020-11-16 | $51.95 | $5.7M | +11.0% | +76.5% | +94.5% |
| FATE | SELL | 2020-01-30 | 2020-02-03 | $25.45 | $636K | +2.5% | +12.1% | +3.7% |
| FATE | SELL | 2019-12-19 | 2019-12-23 | $20.13 | $2.0M | -4.4% | +18.4% | +7.5% |
| FATE | SELL | 2019-10-15 | 2019-10-16 | $14.44 | $607K | +5.4% | +1.0% | +66.9% |
| FATE | SELL | 2019-05-16 | 2019-05-17 | $19.45 | $513K | +7.5% | +3.1% | -5.2% |
| FATE | SELL | 2019-04-18 | 2019-04-19 | $16.01 | $184K | +2.8% | +16.1% | +41.7% |
| FATE | SELL | 2019-04-17 | 2019-04-19 | $16.08 | $643K | +2.8% | +16.1% | +41.7% |
| FATE | SELL | 2019-04-17 | 2019-04-19 | $16.18 | $121K | +2.8% | +16.1% | +41.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.